1. Home
  2. FIBK vs CNTA Comparison

FIBK vs CNTA Comparison

Compare FIBK & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Interstate BancSystem Inc. (DE)

FIBK

First Interstate BancSystem Inc. (DE)

HOLD

Current Price

$35.46

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$39.58

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIBK
CNTA
Founded
1879
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
6.1B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
FIBK
CNTA
Price
$35.46
$39.58
Analyst Decision
Hold
Buy
Analyst Count
8
9
Target Price
$35.63
$43.17
AVG Volume (30 Days)
1.2M
2.5M
Earning Date
04-29-2026
05-13-2026
Dividend Yield
5.46%
N/A
EPS Growth
34.25
29.13
EPS
2.94
N/A
Revenue
N/A
$15,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.91
N/A
P/E Ratio
$12.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.81
$10.95
52 Week High
$39.26
$40.26

Technical Indicators

Market Signals
Indicator
FIBK
CNTA
Relative Strength Index (RSI) 59.16 73.62
Support Level $31.37 $39.16
Resistance Level $36.35 $40.26
Average True Range (ATR) 0.74 0.17
MACD 0.15 -0.48
Stochastic Oscillator 83.70 76.27

Price Performance

Historical Comparison
FIBK
CNTA

About FIBK First Interstate BancSystem Inc. (DE)

First Interstate BancSystem Inc is a financial holding company. It is the parent company of First Interstate Bank, a community bank offering a range of internet, mobile, and other banking and financial services throughout Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. It delivers a range of financial products and services to both retail and commercial customers in industries like agriculture, construction, education, energy, governmental services, healthcare, mining, professional services, retail, tourism and wholesale trade. It generates majority of income from interest charged on loans, and interest and dividends earned on investments.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Share on Social Networks: